Skip to main content
logo
Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.595
+0.005 (0.31%)
Jun 26, 2026, 3:04 PM EDT - Market open

Autolus Therapeutics Revenue

Autolus Therapeutics had revenue of $26.22M in the quarter ending March 31, 2026, with 191.89% growth. This brings the company's revenue in the last twelve months to $92.62M, up 927.90% year-over-year. In the year 2025, Autolus Therapeutics had annual revenue of $75.39M with 652.77% growth.

Revenue (ttm)
$92.62M
Revenue Growth
+927.90%
P/S Ratio
4.65
Revenue / Employee
$122,844
Employees
754
Market Cap
424.50M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202575.39M65.37M652.77%
Dec 31, 202410.01M8.32M489.79%
Dec 31, 20231.70M-4.68M-73.38%
Dec 31, 20226.38M4.87M323.23%
Dec 31, 20211.51M1.27M522.73%
Dec 31, 2020242.00K--
Dec 31, 2019---
Dec 31, 2018---
Sep 30, 2018---
Sep 30, 2017---
Sep 30, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Century Therapeutics109.16M
Enanta Pharmaceuticals69.21M
Editas Medicine38.69M
vTv Therapeutics36.84M
Prelude Therapeutics16.72M
Ovid Therapeutics7.12M
Shattuck Labs1.00M
Revenue Rankings

AUTL News

More News